Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.10.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities

Cancer
Cancer ResearchOncology
2009English

Combination Therapies of Hypomethylating Agents for Elderly Patients With Acute Myeloid Leukemia

Acta Haematologica Polonica
OncologyHematology
2018English

A Phase II Study of Omacetaxine Mepesuccinate for Patients With Higher-Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia After Failure of Hypomethylating Agents

American Journal of Hematology
Hematology
2018English

Therapy-Related Myelodysplastic Syndrome-Acute Myelogenous Leukemia in Patients Treated for Acute Promyelocytic Leukemia: An Emerging Problem

Blood
BiochemistryImmunologyCell BiologyHematology
2002English

Upregulation of Mir-99a Is Associated With Poor Prognosis of Acute Myeloid Leukemia and Promotes Myeloid Leukemia Cell Expansion

Blood
BiochemistryImmunologyCell BiologyHematology
2016English

Autologous Stem Cell Transplantation for Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome

Bone Marrow Transplantation
TransplantationHematology
2005English

Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia, and Acute Myeloid Leukemia Associated With Complete or Partial Monosomy 7

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Biologic Characteristics of Acute Leukemia After Myelodysplastic Syndrome

Blood
BiochemistryImmunologyCell BiologyHematology
1993English

Failure of Hypomethylating Agent–Based Therapy in Myelodysplastic Syndromes

Seminars in Oncology
OncologyHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy